Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Jewish cultural and religious factors and uptake of population-based BRCA testing across denominations: a cohort study.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Population structure and relatedness estimates in a Mexican sample.

Annals of human genetics·2021
Same author

Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes.

BJOG : an international journal of obstetrics and gynaecology·2019
Same author

Attitude towards and factors affecting uptake of population-based BRCA testing in the Ashkenazi Jewish population: a cohort study.

BJOG : an international journal of obstetrics and gynaecology·2019
Same author

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma.

Scientific reports·2018
Same author

Prognostic markers for colorectal cancer: estimating ploidy and stroma.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same journal

Can habitat modification in the native range promote invasion?

Trends in ecology & evolution·2026
Same journal

The host-microbiome dimension of ecological regime shifts.

Trends in ecology & evolution·2026
Same journal

The emerging field of wild animal welfare science.

Trends in ecology & evolution·2026
Same journal

Integrating nutritional mutualists into the evolution of defense.

Trends in ecology & evolution·2026
Same journal

Formation of three great Asian plateaus, climate change, and biodiversity: (Trends Ecol. Evol. 40, 970-982; 2025).

Trends in ecology & evolution·2026
Same journal

Digital twins as a tool for ecosystem research.

Trends in ecology & evolution·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Mutations, evolutionary theory and cancer.

I Tomlinson1

  • 1Cancer Immunology Laboratory, Imperial Cancer Research Fund, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK 0X3 9DU.

Trends in Ecology & Evolution
|January 18, 2011
PubMed
Summary
This summary is machine-generated.

Molecular oncologists often overlook evolutionary principles in cancer development. Incorporating evolutionary theory into tumor mutation analysis can refine our understanding of tumorigenesis.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Related Experiment Videos

Last Updated: Jun 5, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Area of Science:

  • Oncology
  • Evolutionary Biology
  • Genetics

Background:

  • Molecular oncology relies on implicit assumptions about tumor genotype development.
  • These assumptions stem from a classical model of tumorigenesis.
  • Tumor growth shares parallels with organismal evolution.

Purpose of the Study:

  • To highlight the need for integrating evolutionary theory into molecular oncology.
  • To suggest modifications to the classical model of tumorigenesis based on evolutionary principles.
  • To emphasize the importance of considering evolutionary contributions in cancer mutation studies.

Main Methods:

  • Conceptual analysis of classical tumorigenesis models.
  • Comparison of tumor growth dynamics with evolutionary processes.
  • Review of current practices in molecular oncology data analysis.

Main Results:

  • The classical model of tumorigenesis, while useful, may benefit from evolutionary modifications.
  • Evolutionary theory offers a framework to better interpret tumor mutation significance.
  • Current experimental methods and data analysis in molecular oncology are beginning to incorporate evolutionary insights.

Conclusions:

  • A deeper understanding of tumorigenesis requires embracing evolutionary theory.
  • Integrating evolutionary concepts can enhance the interpretation of cancer mutations.
  • Future research in molecular oncology should fully account for evolutionary contributions.